scholarly journals Changes in the Number of Newly Diagnosed Lung Cancer Patients Before and During the COVID-19 Pandemic: A single-Center Experience

2021 ◽  
Author(s):  
Sule Gul ◽  
Mehmet Atilla Uysal ◽  
Atilla Çifter ◽  
Elif Yelda Özgün Niksarlıoğlu ◽  
Deniz Bilici
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Hospital Admissions ◽  
Information Management System ◽  
Tertiary Hospital ◽  
Newly Diagnosed ◽  
Lung Cancer Patients ◽  
Single Center Experience ◽  
Hospital Information Management System ◽  
Epidemic Diseases

Abstract This study was conducted to determine whether there was an effect on the hospital admissions of newly diagnosed lung cancer (NDLC) patients in Turkey during the COVID-19 pandemic. In this retrospective study, NDLC patients were recorded from the Hospital Information Management System between January,1 2015-December, 31, 2020, at our tertiary hospital. The number of NDLC patients diagnosed in 2020 was compared with each year of 2017-2019. Between 2017 and 2020, 15,150 NDLC cases were analyzed. The number of NDLC patients by year were; 4,030 patients in 2017, 4,004 patients in 2018, 4,391 patients in 2019, and 2,725 in 2020, respectively. In 2020, NDLC patients decreased by 38%, 32%, 32% compared to 2019, 2018, and 2017, respectively. The late admission of lung cancer patients might result in the advanced stage, missing the chance for surgery, and decreased survival. Precautions should be considered to diagnose and treat lung cancer patients in specialized centers during a pandemic due to epidemic diseases such as COVID-19.

Prevalence of emotional distress in newly diagnosed lung cancer patients

2009 ◽  
Vol 17 (12) ◽  
pp. 1493-1497 ◽  
Author(s):  
Tracy Steinberg ◽  
Michelle Roseman ◽  
Goulnar Kasymjanova ◽  
Sarah Dobson ◽  
Lucie Lajeunesse ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Emotional Distress ◽  
Newly Diagnosed ◽  
Lung Cancer Patients

35 Changing patterns of hospital admissions for lung cancer patients in Ireland, 2005 to 2014

Lung Cancer ◽  
2016 ◽  
Vol 91 ◽  
pp. S13
Author(s):  
K.I. Quintyne ◽  
T. Mccarthy ◽  
D. Murray ◽  
R. Morgan ◽  
M. Mannix
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Hospital Admissions ◽  
Lung Cancer Patients ◽  
Changing Patterns

scholarly journals P32.02 2020 in Hindsight: Newly Diagnosed Lung Cancer Patients in the Time of COVID-19 at a Tertiary Canadian Cancer Centre

2021 ◽  
Vol 16 (10) ◽  
pp. S1058-S1059
Author(s):  
L. Petersen ◽  
A. Gibson ◽  
K. Gerat ◽  
L. Kinch ◽  
A. Elegbede ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Newly Diagnosed ◽  
Lung Cancer Patients ◽  
Cancer Centre

scholarly journals Case study of an autoantibody panel for early detection of lung cancer and ground-glass nodules

2020 ◽  
Vol 146 (12) ◽  
pp. 3349-3357
Author(s):  
Yunli Huo ◽  
Zijian Guo ◽  
Xuehui Gao ◽  
Zhongjuan Liu ◽  
Ruili Zhang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Lung Disease ◽  
Cancer Patients ◽  
Cancer Diagnosis ◽  
Predictive Value ◽  
Positive Test ◽  
Test Results ◽  
Newly Diagnosed ◽  
Lung Cancer Patients ◽  
Lung Cancer Diagnosis

Abstract Purpose Increasing lung cancer incidence in China with a high death rate due to late diagnosis highlights the need for biomarkers, such as panels of autoantibodies (AAbs), for prediction and early lung cancer diagnosis. We conducted a study to further evaluate the clinical performance of an AAb diagnostic kit. Methods Using enzyme-linked immunosorbent assay, levels of seven AAbs in serum samples from 121 patients with newly diagnosed lung cancer, 84 controls (34 healthy individuals and 50 patients with benign lung disease), and 100 indeterminate solid nodules, were measured. Participants were followed up until 6 months after a positive test result to confirm lung cancer diagnosis. Results The seven AAb concentration was significantly higher in lung cancer patients than in controls (P < 0.05). The seven AAb sensitivity and specificity for newly diagnosed lung cancer were 45.5% and 85.3%, respectively, while the seven AAb combined area under the curve (in lung cancer patients versus controls) was 0.660. Of the 28 patients with solid nodules with positive test results, 8 and 3 were diagnosed with lung cancer and benign lung disease, respectively, during follow-up. The positive predictive value of the experiment was 72.7%. Conclusion Positive AAb test results were associated with a high risk of lung cancer. The seven-AAb panel also had a high predictive value for detecting lung cancer in patients with solid nodules. Our seven lung cancer autoantibody types can provide an important early warning sign in the clinical setting.

Sign in / Sign up

Export Citation Format

Share Document